Showing results (261-270 of 321) with videos related to
Sort By:
Pageof 33
Plos One|November 3, 2016
Cycloheximide Can Induce Bax/Bak Dependent Myeloid Cell Death Independently of Multiple BH3-Only ProteinsKatharine J Goodall, Megan L Finch-Edmondson, Joanne van Vuuren, et al.Molecular Biology of the Cell|November 29, 2023
Quaking isoforms cooperate to promote the mesenchymal phenotypeDaniel P Neumann, Caroline A Phillips, Rachael Lumb, et al.Oncotarget|July 3, 2018
FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1Cheryl Y Brown, Sonia Dayan, Soon Wei Wong, et al.Annals of Surgical Oncology|July 14, 2000
Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival modelD R McCready, J A Chapman, W M Hanna, et al.Breast Cancer Research and Treatment|January 1, 1992
A comparison of all-subset Cox and accelerated failure time models with Cox step-wise regression for node-positive breast cancerJ A Chapman, M E Trudeau, K I Pritchard, et al.Nurse Educator|March 1, 1997
The Iowa Articulation Story. Collaboration worksE McClelland, M A Aulwes, P Bradley, et al.Cell Systems|July 16, 2018
Combinatorial Targeting by MicroRNAs Co-ordinates Post-transcriptional Control of EMTJoseph Cursons, Katherine A Pillman, Kaitlin G Scheer, et al.Plos One|October 3, 2013
Identification of an enhancer that increases miR-200b~200a~429 gene expression in breast cancer cellsJoanne L Attema, Andrew G Bert, Yat-Yuen Lim, et al.RNA (New York, N.Y.)|December 22, 2017
miR-222 isoforms are differentially regulated by type-I interferonCharlotte Nejad, Katherine A Pillman, Katherine J Siddle, et al.Blood|January 1, 1996
Monoclonal antibody 7G3 recognizes the N-terminal domain of the human interleukin-3 (IL-3) receptor alpha-chain and functions as a specific IL-3 receptor antagonistQ Sun, J M Woodcock, A Rapoport, et al.Pageof 33